article thumbnail

Breakthroughs in Computer Aided Drug Design with New Methods of Accelerated Computational Chemistry

Fierce BioTech

Listing Image QuartzListingLogo_250x190_rescale.png Listing Introduction Accelerate drug discovery with agile, scalable, and fast, next-gen computational chemistry with Rescale’s easy to use cloud platform powered by AWS and NVIDIA. Click here to login. Click here to login. On Demand Start Date Tue, 07/25/2023 - 14:00

article thumbnail

BioAscent enhances its computational chemistry services

Drug Discovery Today

Ongoing recruitment strengthens teams in all areas of integrated discovery

article thumbnail

Requirements to Conduct First-in-Human (FIH) Clinical Trials for Biopharmaceuticals

ProRelix Research

The transition of a drug, medical device, or biopharmaceutical from the laboratory bench to bedside involves a long series of steps starting from drug discovery, computational chemistry, in vitro and […] The post Requirements to Conduct First-in-Human (FIH) Clinical Trials for Biopharmaceuticals appeared first on ProRelix Research.

article thumbnail

AI in Drug Discovery - A Highly Opinionated Literature Review (Part III)

Practical Cheminformatics

Property Prediction Machine Learning Methods for Small Data Challenges in Molecular Science [link] Practical guidelines for the use of gradient boosting for molecular property prediction [link] Application of message passing neural networks for molecular property prediction [link] Molecular Similarity Molecular Similarity: Theory, Applications, and (..)

article thumbnail

Patent Highlights: Allosteric AR Modulators, Glycogen Synthase Inhibitors, and More

Drug Hunter

Oral Allosteric AR Modulator s request a trial You don’t have time to read everything, but you can’t afford to fall behind.

article thumbnail

Sygnature Discovery and Daewoong Pharma announce research collaboration

Sygnature Discovery

Our capabilities include medicinal chemistry, in vitro and in vivo biology, HTS, computational chemistry and informatics, DMPK, form and formulation and protein crystallography.

article thumbnail

Some Thoughts on Biotech vs Pharma for Computational Chemists

Practical Cheminformatics

A recent editorial by Dean Brown in J Med Chem and follow-up posts by Keith Hornberger and Derek Lowe prompted me to think about how we train computational chemists and cheminformaticians for careers in drug discovery. It also brought to mind some unique differences between how computational chemistry is practiced in biotech and pharma.